
HDFC Pharma And Healthcare Fund Direct Growth
HDFC Pharma And Healthcare Fund Direct Growth
as on 06 Nov 2026
HDFC Pharma And Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 04 Oct 2023. The current NAV stands at ₹22.8150 as of 06 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 9.20%, Divis Laboratories at 8.02%, Lupin at 5.45%, Max Healthcare Institute at 5.26%, Aster DM Healthcare at 5.18%
Scheme Overview
- Inception Date : 04 Oct 2023
- AUM : ₹3,501.37 Cr
- 3Y Returns (CAGR) : 31.31%
- Expense Ratio : 1.03%
- Min. SIP : ₹100
- Min. Lumpsum : ₹100
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
3Y
₹ 18.95 L
3.50%
₹ 20.40 L
8.00%
₹ 30.04 L
31.31%
Total Investment
₹ 18,00,000
Returns
₹ 12,03,676 (31.31%)
Maturity Value
₹ 30,03,676
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 3,501.37 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹3,501.37 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 94.20% | ||
| Basic Materials | 4.50% | ||
| Other | 1.30% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 9.20% | |
![]() D Divis Laboratories | 8.02% | |
![]() L Lupin | 5.45% | |
![]() M Max Healthcare Institute | 5.26% | |
![]() A Aster DM Healthcare | 5.18% | |
![]() C Cipla | 4.92% | |
![]() A Acutaas Chemicals | 4.50% | |
![]() A Alkem Laboratories | 4.36% | |
![]() A Anthem Biosciences | 4.15% | |
![]() I IPCA Laboratories | 3.50% | |
![]() F Fortis Healthcare | 3.41% | |
![]() G Glenmark Pharmaceuticals | 3.28% | |
![]() L Laurus Labs | 3.17% | |
![]() K Krishna Institute of Medical Sciences | 3.16% | |
![]() G Global Health | 3.08% | |
![]() N Neuland Laboratories | 2.98% | |
![]() V Vijaya Diagnostic Centre | 2.70% | |
![]() M Metropolis Healthcare | 2.54% | |
![]() Z Zydus Life Science | 2.50% | |
![]() W Wockhardt | 2.44% | |
![]() S Shilpa Medicare | 2.28% | |
![]() S Sai Life Sciences | 1.78% | |
![]() E Eris Lifesciences | 1.61% | |
![]() T Thyrocare Technologies | 1.54% | |
![]() T Treps - Tri-Party Repo | 1.49% | |
R Rubicon Research | 1.35% | |
![]() J Jubilant Pharmova | 1.34% | |
![]() B Biocon | 1.33% | |
![]() G Gland Pharma | 1.19% | |
![]() B Bajaj HealthCare | 0.73% | |
![]() N Novartis | 0.64% | |
![]() L Laxmi Dental | 0.63% | |
![]() C Cohance Lifesciences | 0.46% | |
![]() N Net Current Assets | 0.18% | |
![]() T Torrent Pharmaceuticals | 0.00% |
Fund Comparison
Fund Details
52W High NAV
₹ 22.8920
Min. SIP Amount
₹ 100.00
Min. Lumpsum Amount
₹ 100.00
AUM (in Cr.)
₹ 3,501.37
Expense Ratio
1.03%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 16.8320
Inception Date
04 Oct 2023
Fund Age
3 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 1%, if redeemed within 30 days.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Gopal Agrawal | B.E & MBA. |
| Bhagyesh Kagalkar | B.E. (Production) MMS (Finance)- Mumbai University |
| Nikhil Mathur | PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared |
Fund Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
HDFC Mutual Fund
No. of Schemes
83
Total AUM
₹ 8,91,807.79 Cr
Contact Details
HDFC House, 2nd Flr, H.T.Parekh Marg,165-166, Backbay Reclamation,Churchgate, Mumbai - 400 020.
Contact Details
HDFC House, 2nd Flr, H.T.Parekh Marg,165-166, Backbay Reclamation,Churchgate, Mumbai - 400 020.
FAQs
When was HDFC Pharma And Healthcare Fund launched?
What is the current NAV of HDFC Pharma And Healthcare Fund?
What is the AUM of HDFC Pharma And Healthcare Fund?
What is the rate of return of HDFC Pharma And Healthcare Fund?
- In the past 1Y: 28.23%
- In the past 3Y: 31.31%
- In the past 5Y: 0.00%
What is the expense ratio of HDFC Pharma And Healthcare Fund?
What is exit load of HDFC Pharma And Healthcare Fund?
What is the portfolio of HDFC Pharma And Healthcare Fund?
- Sun Pharmaceutical: 9.20%
- Divis Laboratories: 8.02%
- Lupin: 5.45%
- Max Healthcare Institute: 5.26%
- Aster DM Healthcare: 5.18%
Top 3 sectoral holdings include:
- Healthcare: 94.20%
- Basic Materials: 4.50%
- Others: 1.67%
How risky is investing in HDFC Pharma And Healthcare Fund?
Who is the fund manager HDFC Pharma And Healthcare Fund?
What is the minimum investment required in HDFC Pharma And Healthcare Fund?
How to invest in HDFC Pharma And Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App



































